MCED Legislative Comparison
The following chart is a section-by-section summary of the MCED legislation, comparing the legislation introduced in the 118th Congress with the version introduced in the 119th Congress.
Multi-Cancer Early Detection Tests (MCEDs) are simple blood tests that can screen for many types of cancer at once. Congress must seize the opportunity to ensure these cutting-edge tests can be covered under Medicare once they are FDA-approved and proven to have clinical benefit. Doing so has the potential to save lives and revolutionize the way we detect cancer.